Join the Cataract group to help and get support from people like you.
Cataract News
Related terms: Congenital Cataract
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery
THURSDAY, April 10, 2025 – Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction. All...
Access to Ophthalmic Specialty Care Increasingly Challenging in Rural Areas
FRIDAY, Jan. 3, 2025 – Rural areas are increasingly facing ophthalmic subspecialty surgeon shortages, according to a study published online Jan. 2 in JAMA Ophthalmology. Aishah Ahmed, from the Johns ...
AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications
WEDNESDAY, Oct. 23, 2024 – A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at the annual ...
Cataract Surgery Could Save Your Eyesight and Maybe Your Life
TUESDAY, Oct. 22, 2024 – Cataract surgery could restore good vision to older people and by doing so cut their odds for potentially life-threatening falls, a new study finds. Folks who got the...
Cataracts Gone Without Surgery? New Science Suggests It's Possible
MONDAY, Sept. 23, 2024 – Research in rats and hibernating squirrels has pinpointed a naturally occurring protein that appears to reverse cataracts, scientists report. Animal studies don't always pan...
Healthy Tips to Protect Your Eyes' Retinas as You Age
SUNDAY, Sept. 8, 2024 – Getting older tends to go hand in hand with failing vision, but eye experts say there are things you can do to preserve your sight as you age. The risk of age-related macular...
Self-Imposed Use Cessation Dates Tied to Ophthalmic Drop Waste
TUESDAY, July 16, 2024 – Self-imposed use cessation dates (SUCD) for multiuse eye drop bottles leads to significant drug waste and associated costs, according to a report published online July 1...
FDA Medwatch Alert: FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products
September 12, 2023 – The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal...
FDA Medwatch Alert: Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals - Adverse Events After Receiving Eye Injections
ISSUE: At least 43 patients reported adverse events after receiving eye injections of Guardian’s Pharmacy Services compounded triamcinolone-moxifloxacin product during cataract surgery. The patients ...
Icon Bioscience Receives FDA Approval for Dexycu (dexamethasone intraocular suspension) for Treating Inflammation Associated With Cataract Surgery
Newark, CA (February 12, 2018) – Icon Bioscience, Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care th...
Omeros Corporation Announces FDA Approval of Omidria for Use in Pediatric Patients
SEATTLE--(BUSINESS WIRE)--Dec. 12, 2017-- Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...
FDA Medwatch Alert: Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin (TMV) Formulation: FDA Statement - Case of Hemorrhagic Occlusive Retinal Vasculitis
ISSUE: FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV)...
Sun Pharma Receives FDA Approval For BromSite (bromfenac ophthalmic solution)
Mumbai, April 09, 2016: Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today...